{
  "docId": "019de074-0cc8-70d5-8924-3a1b552a09af",
  "docSlug": "77b0d3b8437e31981ed49d98afb5005f",
  "documentTitle": "OmniAb | Investor Conference Presentation Deck | 43 slides",
  "authorId": "omniab",
  "authorName": "OmniAb",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-11-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 12,
  "pageCount": 43,
  "prevPage": 11,
  "nextPage": 13,
  "slideType": "other",
  "function": "present_framework",
  "density": "dense",
  "nDataPoints": 1,
  "notes": "The slide compares human and cow antibody structures, specifically focusing on the 'knob-and-stalk' architecture of the ultralong CDRH3.",
  "elementsJson": null,
  "metadataConfidence": 0.95,
  "imagePath": null,
  "slideHref": "/slides/019de074-0cc8-70d5-8924-3a1b552a09af/12",
  "deckHref": "/decks/019de074-0cc8-70d5-8924-3a1b552a09af",
  "deckJsonHref": "/decks/019de074-0cc8-70d5-8924-3a1b552a09af.json",
  "deckAnchorHref": "/decks/019de074-0cc8-70d5-8924-3a1b552a09af#slide-12",
  "components": [
    {
      "bbox": {
        "h": 0.4,
        "w": 0.3,
        "x": 0.1,
        "y": 0.25
      },
      "kind": "image",
      "text": "Comparison of human and cow antibody structures highlighting CDRH3",
      "attrs": null,
      "subkind": "illustration",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b945efc5-6712-470d-991f-b9ad2cf1cc08",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.6,
        "w": 0.35,
        "x": 0.55,
        "y": 0.25
      },
      "kind": "image",
      "text": "Detailed structural model of CDRH3 knob-and-stalk binding to antigen",
      "attrs": null,
      "subkind": "illustration",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "dcb1afd7-9b52-4fe3-a535-99aa623e5623",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.5,
        "x": 0.04,
        "y": 0.73
      },
      "kind": "list",
      "text": "Novel structure may enable targeting epitopes unreachable by standard antibodies; Long H3 domains can be expressed on human VH framework, or alone as ~5kD Picobodies",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5a643ad5-7f66-4473-9d95-eaa8a77995d6",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.2,
        "x": 0.6,
        "y": 0.85
      },
      "kind": "source-note",
      "text": "Stanfield, et.al. Sci Adv (2020) 6(20): eaba0468.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3a5b59a4-0c17-471b-bc18-7a227618a88d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.6,
        "x": 0.04,
        "y": 0.05
      },
      "kind": "title",
      "text": "OmniTaur: Ultralong CDRH3s Create Novel Binding Domains",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0ca9a3ae-660f-4f8b-8a1c-177bf1b95a49",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.4,
        "x": 0.04,
        "y": 0.12
      },
      "kind": "title",
      "text": "UNIQUE STRUCTURAL FEATURES OF ULTRALONG H3 ANTIBODIES",
      "attrs": null,
      "subkind": "subtitle",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9632eecb-548d-4d79-a294-e1f727f8a797",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 16,
      "from": 7,
      "beatId": "3040f323-ee51-48d4-9506-f542b79a5e56",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Solution",
      "beatSlug": "sequoia-pitch-solution",
      "evidence": "Slides 7-16 present OmniAb's platform and its capabilities.",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": "Turn",
      "parentBeatSlug": "turn"
    }
  ],
  "loops": [
    {
      "to": 16,
      "from": 6,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "d28165e9-330b-4b4c-9bd6-8826c981bf1a",
      "evidence": "Slides 6-16 imply that not using OmniAb's platform may lead to lower success rates for antibody medicines.",
      "position": 0,
      "objective": "Highlight the consequences of not adopting OmniAb's technology",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.6,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}